<?xml version="1.0" encoding="UTF-8"?>
<p>Although many rhinovirus infections are only mildly symptomatic, rhinovirus C has been associated with influenza-like respiratory symptoms and acute exacerbations of asthma in children (
 <xref rid="R5" ref-type="bibr">
  <italic>5</italic>
 </xref>). The elevated virulence of rhinovirus C derives from its unique reliance on the cadherin-related family member 3 (CDHR3) receptor for host cell binding (
 <xref rid="R6" ref-type="bibr">
  <italic>6</italic>
 </xref>). A single-nucleotide polymorphism in 
 <italic>CDHR3</italic> (rs6967330, C529Y) is associated with a 10-fold increase of RV-C binding and progeny yield and is a major risk factor for rhinovirus C infection and asthma (
 <xref rid="R7" ref-type="bibr">
  <italic>7</italic>
 </xref>). The protective 
 <italic>CDHR3</italic>-C
 <sub>529</sub> nonrisk allele has been detected exclusively in modern humans, whereas archaic Neanderthal and Denisovan humans each expressed the ancestral risk allele (
 <xref rid="R8" ref-type="bibr">
  <italic>8</italic>
 </xref>). The origin of rhinovirus C and the spread of the protective allele among modern human populations is thought to have occurred â‰ˆ8,000 years ago (
 <xref rid="R9" ref-type="bibr">
  <italic>9</italic>
 </xref>).
</p>
